• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多参数磁共振成像的栖息地分析预测高级别浆液性卵巢癌患者的预后:一项多中心研究

mpMRI-based habitat analysis for predicting prognoses in patients with high-grade serous ovarian cancer: a multicenter study.

作者信息

Bi Qiu, Miao Kun, Liu Yang, Yang Jing, Zhou Ao, Shi Wenwei, Lei Ying, Wu Yunzhu, Song Yang, Ai Conghui, Li Haiming, Qiang Jingwei

机构信息

Department of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.

Department of MRI, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

出版信息

Abdom Radiol (NY). 2025 May 29. doi: 10.1007/s00261-025-05004-9.

DOI:10.1007/s00261-025-05004-9
PMID:40439719
Abstract

PURPOSE

To evaluate the value of multiparametric MRI (mpMRI)-based habitat analysis for predicting prognoses in patients with high-grade serous ovarian cancer (HGSOC), and to develop combined models by integrating habitat analysis with clinical predictors.

METHODS

This retrospective study included 503 HGSOC patients from four centers. A K-means algorithm was used to identify voxel clusters and generate habitats on mpMRI. Radiomics features were extracted from each habitat sub-region. After feature selection, habitat models were developed to predict overall survival (OS) and progression-free survival (PFS). Cox regression analyses were performed to identify clinical predictors and construct clinical models. Combined models were developed by integrating habitat signatures with clinical predictors. Model performance was evaluated using C-index and time-dependent receiver operating characteristic area under the curves (AUCs).

RESULTS

Compared with the clinical models (OS: 0.713 and 0.695; PFS: 0.727 and 0.700) and habitat models (OS: 0.707 and 0.672; PFS: 0.627 and 0.641), the combined models integrating habitat features and clinical independent predictors such as neoadjuvant chemotherapy (OS: 0.752 and 0.745; PFS: 0.784 and 0.754) achieved the highest C-indices for predicting OS and PFS in the internal validation cohort and external test cohort. The combined models also achieved the highest AUCs in all cohorts.

CONCLUSION

The habitat models based on mpMRI demonstrated potential value in predicting the prognoses of HGSOC patients, but no significant advantages over the clinical models. The combined models were expected to improve the prognoses from the level of individual clinical characteristics and habitat features reflecting intratumoral heterogeneity.

摘要

目的

评估基于多参数磁共振成像(mpMRI)的栖息地分析在预测高级别浆液性卵巢癌(HGSOC)患者预后中的价值,并通过将栖息地分析与临床预测因素相结合来开发联合模型。

方法

这项回顾性研究纳入了来自四个中心的503例HGSOC患者。采用K均值算法识别体素簇并在mpMRI上生成栖息地。从每个栖息地子区域提取影像组学特征。经过特征选择后,开发栖息地模型以预测总生存期(OS)和无进展生存期(PFS)。进行Cox回归分析以识别临床预测因素并构建临床模型。通过将栖息地特征与临床预测因素相结合来开发联合模型。使用C指数和曲线下时间依赖性受试者操作特征面积(AUC)评估模型性能。

结果

与临床模型(OS:0.713和0.695;PFS:0.727和0.700)和栖息地模型(OS:0.707和0.672;PFS:0.627和0.641)相比,整合栖息地特征和新辅助化疗等临床独立预测因素的联合模型(OS:0.752和0.745;PFS:0.784和0.754)在内部验证队列和外部测试队列中预测OS和PFS时获得了最高的C指数。联合模型在所有队列中也获得了最高的AUC。

结论

基于mpMRI的栖息地模型在预测HGSOC患者预后方面显示出潜在价值,但与临床模型相比没有显著优势。联合模型有望从反映肿瘤内异质性的个体临床特征和栖息地特征水平改善预后。

相似文献

1
mpMRI-based habitat analysis for predicting prognoses in patients with high-grade serous ovarian cancer: a multicenter study.基于多参数磁共振成像的栖息地分析预测高级别浆液性卵巢癌患者的预后:一项多中心研究
Abdom Radiol (NY). 2025 May 29. doi: 10.1007/s00261-025-05004-9.
2
Habitat Radiomics Based on MRI for Predicting Platinum Resistance in Patients with High-Grade Serous Ovarian Carcinoma: A Multicenter Study.基于 MRI 的肿瘤微环境放射组学预测高级别浆液性卵巢癌铂耐药:多中心研究。
Acad Radiol. 2024 Jun;31(6):2367-2380. doi: 10.1016/j.acra.2023.11.038. Epub 2023 Dec 21.
3
Radiomics Analysis of PET and CT Components of F-FDG PET/CT Imaging for Prediction of Progression-Free Survival in Advanced High-Grade Serous Ovarian Cancer.用于预测晚期高级别浆液性卵巢癌无进展生存期的¹⁸F-FDG PET/CT成像中PET与CT成分的影像组学分析
Front Oncol. 2021 Apr 13;11:638124. doi: 10.3389/fonc.2021.638124. eCollection 2021.
4
Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.基于MRI的影像组学列线图预测晚期高级别浆液性卵巢癌的铂耐药性
Eur Radiol. 2023 Aug;33(8):5298-5308. doi: 10.1007/s00330-023-09552-w. Epub 2023 Mar 30.
5
F-FDG PET/CT-based habitat radiomics combining stacking ensemble learning for predicting prognosis in hepatocellular carcinoma: a multi-center study.基于 F-FDG PET/CT 的生境放射组学结合堆叠集成学习预测肝细胞癌预后的多中心研究。
BMC Cancer. 2024 Nov 27;24(1):1457. doi: 10.1186/s12885-024-13206-5.
6
A multi-modal model integrating MRI habitat and clinicopathology to predict platinum sensitivity in patients with high-grade serous ovarian cancer: a diagnostic study.整合MRI特征与临床病理的多模态模型预测高级别浆液性卵巢癌患者铂敏感性:一项诊断性研究
Int J Surg. 2025 Jul 1;111(7):4222-4233. doi: 10.1097/JS9.0000000000002524. Epub 2025 May 20.
7
Prognostic Assessment in Patients With Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Using MRI-Based Radiomics.基于MRI的放射组学对原发性中枢神经系统弥漫性大B细胞淋巴瘤患者的预后评估
J Magn Reson Imaging. 2025 Mar;61(3):1142-1152. doi: 10.1002/jmri.29533. Epub 2024 Jul 6.
8
Development and validation of a dynamic contrast-enhanced magnetic resonance imaging-based habitat and peritumoral radiomic model to predict axillary lymph node metastasis in patients with breast cancer: a retrospective study.基于动态对比增强磁共振成像的乳腺癌患者腋窝淋巴结转移预测的瘤周放射组学模型的开发与验证:一项回顾性研究
Quant Imaging Med Surg. 2024 Dec 5;14(12):8211-8226. doi: 10.21037/qims-24-558. Epub 2024 Oct 31.
9
Multitask prediction models for serous ovarian cancer by preoperative CT image assessments based on radiomics.基于影像组学的术前CT图像评估对浆液性卵巢癌的多任务预测模型
Front Med (Lausanne). 2024 Feb 6;11:1334062. doi: 10.3389/fmed.2024.1334062. eCollection 2024.
10
CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer.基于 CT 的肿瘤内异质性定量分析预测非小细胞肺癌新辅助免疫化疗的病理完全缓解。
Front Immunol. 2024 Jun 12;15:1414954. doi: 10.3389/fimmu.2024.1414954. eCollection 2024.

本文引用的文献

1
Development and Validation of a Nomogram Based on Multiparametric MRI for Predicting Lymph Node Metastasis in Endometrial Cancer: A Retrospective Cohort Study.基于多参数磁共振成像预测子宫内膜癌淋巴结转移的列线图的开发与验证:一项回顾性队列研究
Acad Radiol. 2025 May;32(5):2751-2762. doi: 10.1016/j.acra.2024.12.008. Epub 2024 Dec 27.
2
Long-term outcomes of PARP inhibitors in ovarian cancer: survival, adverse events, and post-progression insights.PARP 抑制剂在卵巢癌中的长期疗效:生存、不良事件和进展后洞察。
ESMO Open. 2024 Nov;9(11):103984. doi: 10.1016/j.esmoop.2024.103984. Epub 2024 Nov 13.
3
Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis.
考虑到近期一线治疗进展,术后残留病灶对上皮性卵巢癌生存的影响:一项系统评价和荟萃分析
Gynecol Oncol. 2023 Oct 27;179:24-32. doi: 10.1016/j.ygyno.2023.10.018.
4
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning.基于CT的深度学习预测接受贝伐单抗治疗的上皮性卵巢癌患者的预后
NPJ Precis Oncol. 2024 Sep 13;8(1):202. doi: 10.1038/s41698-024-00688-6.
5
Predicting gastric cancer response to anti-HER2 therapy or anti-HER2 combined immunotherapy based on multi-modal data.基于多模态数据预测胃癌对抗 HER2 治疗或抗 HER2 联合免疫治疗的反应。
Signal Transduct Target Ther. 2024 Aug 26;9(1):222. doi: 10.1038/s41392-024-01932-y.
6
Estimating pathological prognostic factors in epithelial ovarian cancers using apparent diffusion coefficients of functional tumor volume.利用功能肿瘤体积的表观扩散系数估算上皮性卵巢癌的病理预后因素。
Eur J Radiol. 2024 Jul;176:111514. doi: 10.1016/j.ejrad.2024.111514. Epub 2024 May 18.
7
Survival time prediction in patients with high-grade serous ovarian cancer based on F-FDG PET/CT- derived inter-tumor heterogeneity metrics.基于 F-FDG PET/CT 衍生的肿瘤间异质性指标预测高级别浆液性卵巢癌患者的生存时间。
BMC Cancer. 2024 Mar 12;24(1):337. doi: 10.1186/s12885-024-12087-y.
8
The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients.卵巢癌患者获得性继发性铂耐药的不良预后
Cancers (Basel). 2024 Feb 2;16(3):641. doi: 10.3390/cancers16030641.
9
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
10
Habitat Radiomics Based on MRI for Predicting Platinum Resistance in Patients with High-Grade Serous Ovarian Carcinoma: A Multicenter Study.基于 MRI 的肿瘤微环境放射组学预测高级别浆液性卵巢癌铂耐药:多中心研究。
Acad Radiol. 2024 Jun;31(6):2367-2380. doi: 10.1016/j.acra.2023.11.038. Epub 2023 Dec 21.